Bibliografia aggiornata 

STUDI SU PMA -ZEOLITE 2025-2012 /2006-2012

REVIEW CHIMICA DELLA PMA-ZEOLITE E APPLICAZIONI MEDICHE

Aleksandar Bulog et al. PMA-Zeolite: Chemistry and Diverse Medical Applications, J. Funct. Biomater. 2024,

STUDIO NON INTEVENTISTICO OSSERVAZIONALE SU RIDUZIONE DI SINTOMI NELLA SINDROME DELL'INTESTINO IRRITABILE

Wilhelm Mosgoeller et al. PMA – Zeolite (Clinoptilolite) in the Management of Irritable Bowel Syndrome – a Non-Interventional Study, Gastroenterol 2024

STUDIO IN VIVO SULLA RIDUZIONE DEI LIVELLI DI GLUCOSIO NEL SANGUE

Rumenka MarkoskaStudy of zeolite clinoptilolite D-glucose adsorption properties in vitro and in vivo, Chemico-Biological Interactions 2023

OSTEOPOROSI PARAMETRI CLINICI DOPO 5 ANNI Double Blind Randomized Controlled Trial

- Sandra Kraljevic´ Pavelic´ et al Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial, Frontiers in medicine 2022

STUDIO DI SICUREZZA: CONCENTRAZIONI DI MINERALI E INQUINANTI 2022 IN TRE STUDI CLINICI

- Sandra Kraljevic´ Pavelic´ et al. ,Clinical Evaluation of a Defined Zeolite-Clinoptilolite Supplementation Effect on the Selected Blood Parameters of Patients, Frontiers in Medicine, 2022

ANALISI DELLA SOPRAVVIVENZA FOLLOW UP STUDIO NEUROPATIA POST-CHEMIOTERAPICA Double Blind Randomized Controlled Trial

-Maria Giuseppa Vitale, Survival analyses Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy,  Frontiers in Pharmacology, 2022

MARKERS DELLA SINDROME DELL'INTESTINO IRRITABILE 2021 Double Blind Randomized Controlled Trial

-Ventzislav Petkov et al.,PMA-zeolite can modulate inflammation associated markers in irritable bowel disease – an explorative randomized, double blinded, controlled pilot trial, Neuroendocrinology Letters Volume 42 No. 1 2021

NEUROPATIA POST-CHEMIOTERAPICA 2020 Double Blind Randomized Controlled Trial

-Maria Giuseppa Vitale et al. A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Eects, in Particular, Peripheral Neuropathy, Molecules 2020

OSTEOPOROSI 2020 Double Blind Randomized Controlled Trial

- Sandra Kraljević Pavelić et al. Treatment of osteoporosis with a modified zeolite shows beneficial effects in an osteoporotic rat model and a human clinical trial, Experimental Biology and Medicine 2020;

REVIEW 2019

-Andrea Mastinu et al.,Zeolite Clinoptilolite: Therapeutic Virtues of an Ancient Mineral, Molecules 2019

REVIEW 2018

- Sandra Kraljevic´ Pavelic´ et al. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo, Frontiers in Pharmacology, 2018

RIDUZIONE DI ALLUMINIO IN VIVO 2017

- Sandra Kraljević Pavelić et al.Novel, oxygenated clinoptilolite material efficiently removes aluminium from aluminium chloride-intoxicated rats in vivo, Microporous and Mesoporous Materials 2017

INTEGRITA' DELLA BARRIERA GASTRO INTESTINALE - GOLD STANDARD STUDY 2015 - Double Blind Randomized Controlled Trial

- Manfred Lamprecht1 et al. Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redox-biology and performance in aerobically trained subjects, Journal of the International Society of Sports Nutrition, 2015

EFFETTO DEL SILICIO ORGANICO 2013

- Lela Munjas Jurkić et al.,Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: New perspectives for therapy, Nutrition & Metabolism, 2013

NEURODEGENERAZIONE IN VITRO e IN VIVO 2012

- Mery Montinaro et al. Dietary zeolite supplementation reduces oxidative damage and plaque generation in the brain of an Alzheimer's disease mouse model, Life Sciences 2012

STUDI SU PMA -ZEOLITE 2006-2013

• Thoma, W. (2006): Clinical observation of the use of activated zeolite (= PMA zeolite) since April 2000. 
• Knapitsch, Schmölzer, (2004): Randomized double-blind placebo-controlled study with Panaceo Sport on lactate levels and performance improvement 
• Thoma, Gunzer, (2006) Clinical observation: The antioxidant effect of active volcanic mineral zeolite
  (PMA zeolite) on the oxidative system
• Abuja, P.M. (2006): An investigation of the antioxidant activities of PANACEO
• Schulz, N., (2007): Practical report concerning the use of the preparation Panaceo MED in the context of irritable bowel syndrome since 2004
• Bachl, N., (2011) Evaluation of the results of a randomised, double-blind study with Panaceo Sport to assess the effect on physical performance parameters 
• Thoma, (2011): Clinical Observation of Administration of Panaceo-med (Representative Sample of Patients) 
• Triebnig, (2011): Activated natural zeolite clinoptilolite in complementary medicine. Proven roborans in severe diseases, recommended adjuvant in chemo- and radiotherapy. (Note: Evaluation of 150 representative patient records from a long-term application observation on over 2,000 patients in the form of documented medical cases over the period of 10 years using PMA zeolite)
• Weber D., (2012): Study on the use of zeolite in the adjuvant treatment of eating disorders especially with regard to BMI and liver and kidney parameters
• Oberwinkler (2013): Influence of activated (modified) natural zeolite clinoptilolite to relieve the liver